Discontinued — last reported Q3 '19
Current Liabilities
Accrued Expenses
ResMed Accrued Expenses increased by 14.0% to $446.15M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.5%, from $386.33M to $446.15M. Over 4 years (FY 2021 to FY 2025), Accrued Expenses shows an upward trend with a 5.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ3 2019
How to read this metric
A steady balance is normal, but a rapid increase could indicate rising operational costs or delays in vendor invoicing.
Detailed definition
This represents liabilities for expenses that have been incurred but not yet invoiced or paid, such as utilities, profes...
Peer comparison
Standard current liability found in almost all corporate balance sheets.
Metric ID:
accrued_expensesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $320.60M | $274.11M | $286.80M | $326.28M | $344.72M | $324.06M | $312.17M | $347.35M | $365.66M | $348.26M | $332.14M | $356.08M | $377.68M | $365.75M | $352.54M | $386.33M | $402.25M | $395.83M | $391.50M | $446.15M |
| QoQ Change | — | -14.5% | +4.6% | +13.8% | +5.7% | -6.0% | -3.7% | +11.3% | +5.3% | -4.8% | -4.6% | +7.2% | +6.1% | -3.2% | -3.6% | +9.6% | +4.1% | -1.6% | -1.1% | +14.0% |
| YoY Change | — | — | — | — | +7.5% | +18.2% | +8.8% | +6.5% | +6.1% | +7.5% | +6.4% | +2.5% | +3.3% | +5.0% | +6.1% | +8.5% | +6.5% | +8.2% | +11.1% | +15.5% |
Range$274.11M – $446.15M
CAGR+7.2%
Avg YoY Growth+8.0%
Median YoY Growth+7.0%
Accrued Expenses at Other Companies
Frequently Asked Questions
- What is ResMed's accrued expenses?
- ResMed (RMD) reported accrued expenses of $446.15M in Q1 2026.
- How has ResMed's accrued expenses changed year-over-year?
- ResMed's accrued expenses increased by 15.5% year-over-year, from $386.33M to $446.15M.
- What is the long-term trend for ResMed's accrued expenses?
- Over 4 years (2021 to 2025), ResMed's accrued expenses has grown at a 5.8% compound annual growth rate (CAGR), from $320.60M to $402.25M.
- What does accrued expenses mean?
- Expenses the company has incurred but has not yet received a bill for or paid.